4.7 Article

Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides

Journal

MOLECULAR NUTRITION & FOOD RESEARCH
Volume 59, Issue 11, Pages 2243-2254

Publisher

WILEY
DOI: 10.1002/mnfr.201500182

Keywords

Antimicrobial peptide; Circular dichroism; Milk; Peptide database; Virtual screening

Funding

  1. China Scholarship Council (CSC) [201206790009]

Ask authors/readers for more resources

Scope: Milk provides a wide range of bioactive substances, such as antimicrobial peptides and proteins. Our study aimed to identify novel antimicrobial peptides naturally present in milk. Methods and results: The components of an endogenous bovine milk peptide database were virtually screened for charge, amphipathy, and predicted secondary structure. Thus, 23 of 248 screened peptides were identified as candidates for antimicrobial effects. After commercial synthesis, their antimicrobial activities were determined against Escherichia coli NEB5 alpha, E. coli ATCC25922, and Bacillus subtilis ATCC6051. In the tested concentration range (<2 mM), bacteriostatic activity of 14 peptides was detected including nine peptides inhibiting both Gram-positive and Gram-negative bacteria. The most effective fragment was TKLTEEEKN-RLNFLKKISQRYQKFALPQYLK corresponding to alpha(S2)-casein(151-181), with minimum inhibitory concentration (MIC) of 4.0 mu M against B. subtilis ATCC6051, and minimum inhibitory concentrations of 16.2 mu M against both E. coli strains. Circular dichroism spectroscopy revealed conformational changes of most active peptides in a membrane-mimic environment, transitioning from an unordered to alpha-helical structure. Conclusion: Screening of food peptide databases by prediction tools is an efficient method to identify novel antimicrobial food-derived peptides. Milk-derived antimicrobial peptides may have potential use as functional food ingredients and help to understand the molecular mechanisms of anti-infective milk effects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

High-resolution crystal structures of two prototypical ?- and ?-herpesviral nuclear egress complexes unravel the determinants of subfamily specificity

Yves A. Muller, Sigrun Haege, Sewar Alkhashrom, Tobias Hoellriegl, Sebastian Weigert, Simon Dolles, Kerstin Hof, Sascha A. Walzer, Claudia Egerer-Sieber, Marcus Conrad, Stephanie Holst, Josephine Loesing, Eric Sonntag, Heinrich Sticht, Jutta Eichler, Manfred Marschall

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Biochemical Research Methods

Untargeted Proteomics-Based Profiling for the Identification of Novel Processing-Induced Protein Modifications in Milk

Jasmin Meltretter, Johannes Wuest, Daniel Dittrich, Johannes Lach, Jonas Ludwig, Jutta Eichler, Monika Pischetsrieder

JOURNAL OF PROTEOME RESEARCH (2020)

Article Multidisciplinary Sciences

Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects

Angela Tomasovic, Theresa Brand, Constanze Schanbacher, Sofia Kramer, Martin W. Huemmert, Patricio Godoy, Wolfgang Schmidt-Heck, Peter Nordbeck, Jonas Ludwig, Susanne Homann, Armin Wiegering, Timur Shaykhutdinov, Christoph Kratz, Ruth Knuechel, Hans-Konrad Mueller-Hermelink, Andreas Rosenwald, Norbert Frey, Jutta Eichler, Dobromir Dobrev, Ali El-Armouche, Jan G. Hengstler, Oliver J. Mueller, Karsten Hinrichs, Friederike Cuello, Alma Zernecke, Kristina Lorenz

NATURE COMMUNICATIONS (2020)

Review Virology

Nuclear Egress Complexes of HCMV and Other Herpesviruses: Solving the Puzzle of Sequence Coevolution, Conserved Structures and Subfamily-Spanning Binding Properties

Manfred Marschall, Sigrun Haege, Marcus Conrad, Sewar Alkhashrom, Jintawee Kicuntod, Johannes Schweininger, Mark Kriegel, Josephine Loesing, Julia Tillmanns, Frank Neipel, Jutta Eichler, Yves A. Muller, Heinrich Sticht

VIRUSES-BASEL (2020)

Article Chemistry, Medicinal

Exploring Viral Interference Using Peptides: Molecular Determinants of HIV-1 Inhibition by a Peptide Derived from Human Pegivirus-1 Envelope Protein E2

Rebecca Hoffmann, Tamara Ruegamer, Johanna Schaubaecher, Anette Rohrhofer, Peter Kirmess, Karen M. Fiebig, Barbara Schmidt, Jutta Eichler

Summary: Co-infection with HPgV-1 can benefit disease progression in HIV-1-infected individuals, with the peptide P6-2 showing inhibitory activity against HIV-1 by interacting with the envelope glycoprotein gp120.

CHEMMEDCHEM (2021)

Article Virology

Properties of Oligomeric Interaction of the Cytomegalovirus Core Nuclear Egress Complex (NEC) and Its Sensitivity to an NEC Inhibitory Small Molecule

Jintawee Kicuntod, Sewar Alkhashrom, Sigrun Hage, Benedikt Diewald, Regina Muller, Friedrich Hahn, Peter Lischka, Heinrich Sticht, Jutta Eichler, Manfred Marschall

Summary: This study investigates the oligomeric interaction of HCMV core NEC and the antiviral activity of targeted inhibitors, suggesting the oligomeric binding pattern and drug-accessible complex as validated antiviral drug targets. The research provides insights into the formation of HCMV core NEC and the potential for developing new antiviral strategies.

VIRUSES-BASEL (2021)

Article Virology

Exploring the Human Cytomegalovirus Core Nuclear Egress Complex as a Novel Antiviral Target: A New Type of Small Molecule Inhibitors

Sewar Alkhashrom, Jintawee Kicuntod, Sigrun Haege, Johannes Schweininger, Yves A. Muller, Peter Lischka, Manfred Marschall, Jutta Eichler

Summary: The study identified a new type of small molecule inhibitors that can inhibit HCMV core NEC formation and have antiviral effects on HCMV infection.

VIRUSES-BASEL (2021)

Article Multidisciplinary Sciences

A PROSS-designed extensively mutated estrogen receptor α variant displays enhanced thermal stability while retaining native allosteric regulation and structure

Mark Kriegel, Hanna J. Wiederanders, Sewar Alkhashrom, Jutta Eichler, Yves A. Muller

Summary: The application of PROSS server algorithms enabled the development of variant ERPRS* with 24 amino acid substitutions, leading to improved production rates, crystallization, and thermal stability. Despite 10% amino acid substitutions, ERPRS* preserved the allosteric regulatory behaviors of nuclear receptors, suggesting promise for developing novel modulators targeting hER alpha.

SCIENTIFIC REPORTS (2021)

Article Immunology

A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model

Antonia Sophia Peter, Edith Roth, Sebastian R. Schulz, Kirsten Fraedrich, Tobit Steinmetz, Dominik Damm, Manuela Hauke, Elie Richel, Sandra Mueller-Schmucker, Katharina Habenicht, Valentina Eberlein, Leila Issmail, Nadja Uhlig, Simon Dolles, Eva Gruner, David Peterhoff, Sandra Ciesek, Markus Hoffmann, Stefan Pohlmann, Paul F. McKay, Robin J. Shattock, Roman Wolfel, Eileen Socher, Ralf Wagner, Jutta Eichler, Heinrich Sticht, Wolfgang Schuh, Frank Neipel, Armin Ensser, Dirk Mielenz, Matthias Tenbusch, Thomas H. Winkler, Thomas Grunwald, Klaus Uberla, Hans-Martin Jack

Summary: TRIANNI mice were used to generate 29 hybridoma antibodies that reacted with the SARS-CoV-2 spike protein, and identified two clusters of neutralizing antibodies targeting different regions of the spike protein. These neutralizing antibodies significantly reduced viral spread and protected mice from SARS-CoV-2-induced weight loss, showing potential for therapy and prophylaxis of COVID-19.

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Systematic Evaluation of Fluorination as Modification for Peptide-Based Fusion Inhibitors against HIV-1 Infection

Susanne Huhmann, Elisabeth K. Nyakatura, Anette Rohrhofer, Johann Moschner, Barbara Schmidt, Jutta Eichler, Christian Roth, Beate Koksch

Summary: This study evaluated a fluorinated peptide inhibitor which showed the ability to block HIV-1 infection of target cells at nanomolar levels, indicating that fluorinated amino acids are suitable tools for the development of novel peptide therapeutics.

CHEMBIOCHEM (2021)

Article Clinical Neurology

A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro

Isabelle Aillaud, Senthilvelrajan Kaniyappan, Ram Reddy Chandupatla, Lisa Marie Ramirez, Sewar Alkhashrom, Jutta Eichler, Anselm H. C. Horn, Markus Zweckstetter, Eckhard Mandelkow, Heinrich Sticht, Susanne Aileen Funke

Summary: The study suggests that ISAD1 and related D-amino acid peptides may be helpful in the treatment of Alzheimer's disease by inhibiting Tau fibrillization and preventing its toxicity.

ALZHEIMERS RESEARCH & THERAPY (2022)

Article Biochemistry & Molecular Biology

The crystal structure of the varicella-zoster Orf24-Orf27 nuclear egress complex spotlights multiple determinants of herpesvirus subfamily specificity

Johannes Schweininger, Mark Kriegel, Sigrun Hage, Marcus Conrad, Sewar Alkhashrom, Josephine Losing, Sigrid Weiler, Julia Tillmanns, Claudia Egerer-Sieber, Andrea Decker, Tihana Lenac Rovis, Jutta Eichler, Heinrich Sticht, Manfred Marschall, Yves A. Muller

Summary: The formation of the core nuclear egress complex (NEC) in varicella-zoster virus (VZV) displays subfamily-specific features. Understanding these features is crucial for developing drugs that target multiple herpesviruses.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Smaller, Stronger, More Stable: Peptide Variants of a SARS-CoV-2 Neutralizing Miniprotein

Lucas Weissenborn, Elie Richel, Helena Hueseman, Julia Welzer, Silvan Beck, Simon Schaefer, Heinrich Sticht, Klaus Ueberla, Jutta Eichler

Summary: Using the structure of a de novo designed miniprotein (LCB1) in complex with the receptor binding domain (RBD) of the SARS-CoV-2 spike protein, truncated peptide variants of LCB1 were generated and characterized. These variants, which retained virus neutralizing potency against different SARS-CoV-2 variants of concern (VOC), showed even stronger antiviral activity than the full-length peptide. The cyclic variant of the two-helix peptides exhibited significantly improved proteolytic stability, making it a better candidate for SARS-CoV-2 therapy. These peptides can also be chemically modified to further stabilize them against degradation and enhance their virus neutralizing capacity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Medicinal

A Peptide Inhibitor of the Human Cytomegalovirus Core Nuclear Egress Complex

Sewar Alkhashrom, Jintawee Kicuntod, Katharina Stillger, Tamara Luetzenburg, Christian Anzenhofer, Ines Neundorf, Manfred Marschall, Jutta Eichler

Summary: The study identifies a peptide that can interfere with human cytomegalovirus infection and inhibit the interaction of viral proteins pUL50 and pUL53, indicating its potential as a target for new antiviral drugs.

PHARMACEUTICALS (2022)

Article Biology

Computational Characterization of the Binding Properties of the HIV1-Neutralizing Antibody PG16 and Design of PG16-Derived CDRH3 Peptides

Manuel Deubler, Lucas Weissenborn, Simon Leukel, Anselm H. C. Horn, Jutta Eichler, Heinrich Sticht

Summary: PG16 is a broadly neutralizing antibody that binds to the gp120 subunit of the HIV-1 Env protein. Sulfation of Tyr100H in the CDRH3 residue enhances interactions with gp120 and stabilizes the protein-protein contacts and interactions with the gp120 glycan shield. PG16-CDRH3 can be used as a template to develop peptide mimetics as potential inhibitors of HIV invasion.

BIOLOGY-BASEL (2023)

No Data Available